<?xml version="1.0" encoding="UTF-8"?>
<html xmlns="http://www.w3.org/1999/xhtml">
 <head charset="UTF-8"/>
 <style> * { font-family : helvetica;} .font16 { font-size : 16; } .font17 { font-size : 17; } .font19 { font-size : 19; } .font21 { font-size : 21; } .font10 { font-size : 10; } .font11 { font-size : 11; } .font28 { font-size : 28; } .font12 { font-size : 12; } .font13 { font-size : 13; } .font30 { font-size : 30; } .font14 { font-size : 14; }</style>
 <body>
  <p>
   <span class="font30">patients </span>
   <span class="font28">liver </span>
   <span class="font21">COVID- </span>
   <span class="font19">disease </span>
   <span class="font17">risk </span>
   <span class="font16">care </span>
   <span class="font16">severe </span>
   <span class="font16">chronic </span>
   <span class="font14">SARS-CoV- </span>
   <span class="font14">treatment </span>
   <span class="font14">{border-style </span>
   <span class="font14">coronavirus </span>
   <span class="font14">px;} </span>
   <span class="font13">#ffffff;} </span>
   <span class="font13">clinical </span>
   <span class="font13">course </span>
   <span class="font13">local </span>
   <span class="font13">ahead </span>
   <span class="font13">cirrhosis </span>
   <span class="font13">print] </span>
   <span class="font12">drugs </span>
   <span class="font12">infection </span>
   <span class="font12">transplantation </span>
   <span class="font12">Patients </span>
   <span class="font12">virus </span>
   <span class="font12">COVID-. </span>
   <span class="font12">[], </span>
   <span class="font12">acute </span>
   <span class="font12">considerations </span>
   <span class="font12">viral </span>
   <span class="font12">•In </span>
   <span class="font12">antiviral </span>
   <span class="font12">associated </span>
   <span class="font12">case </span>
   <span class="font12">drug </span>
   <span class="font12">efficacy </span>
   <span class="font12">hepatitis </span>
   <span class="font12">syndrome </span>
   <span class="font11">COVID-: </span>
   <span class="font11">However, </span>
   <span class="font11">considered </span>
   <span class="font11">immunosuppressive </span>
   <span class="font11">individual </span>
   <span class="font11">px; </span>
   <span class="font11">respiratory </span>
   <span class="font11">trial </span>
   <span class="font11">vitro </span>
   <span class="font11">{font-family </span>
   <span class="font11">ALT </span>
   <span class="font11">RNA </span>
   <span class="font11">addition, </span>
   <span class="font11">advanced </span>
   <span class="font11">available </span>
   <span class="font11">data </span>
   <span class="font11">decompensated </span>
   <span class="font11">diseases </span>
   <span class="font11">exposure </span>
   <span class="font11">font-size </span>
   <span class="font11">including </span>
   <span class="font11">management </span>
   <span class="font11">medical </span>
   <span class="font11">patient </span>
   <span class="font11">provide </span>
   <span class="font11">reports </span>
   <span class="font11">surveillance </span>
   <span class="font11">COVID-, </span>
   <span class="font11">HCC </span>
   <span class="font11">Thus, </span>
   <span class="font11">currently </span>
   <span class="font11">double; </span>
   <span class="font11">experience </span>
   <span class="font11">factors </span>
   <span class="font11">healthcare </span>
   <span class="font11">increased </span>
   <span class="font11">influenza </span>
   <span class="font11">outpatient </span>
   <span class="font11">patients. </span>
   <span class="font11">potential </span>
   <span class="font11">providers </span>
   <span class="font11">receptor </span>
   <span class="font11">regards </span>
   <span class="font11">remains </span>
   <span class="font11">require </span>
   <span class="font11">specialised </span>
   <span class="font11">testing </span>
   <span class="font11">(e.g. </span>
   <span class="font11">General </span>
   <span class="font11">SARS-CoV-, </span>
   <span class="font11">avoid </span>
   <span class="font11">based </span>
   <span class="font11">bold </span>
   <span class="font11">border-color </span>
   <span class="font11">border-width </span>
   <span class="font11">centres </span>
   <span class="font11">chloroquine </span>
   <span class="font11">cohorts </span>
   <span class="font11">consider </span>
   <span class="font11">disease, </span>
   <span class="font11">early </span>
   <span class="font11">elevations </span>
   <span class="font11">health </span>
   <span class="font11">immune </span>
   <span class="font11">importance </span>
   <span class="font11">infection. </span>
   <span class="font11">inhibitors </span>
   <span class="font11">inpatient </span>
   <span class="font11">non-alcoholic </span>
   <span class="font11">novel </span>
   <span class="font11">pandemic </span>
   <span class="font11">performed </span>
   <span class="font11">prevent </span>
   <span class="font11">procedures </span>
   <span class="font11">reactivation </span>
   <span class="font11">recommend </span>
   <span class="font11">recommendations </span>
   <span class="font11">shown </span>
   <span class="font11">solid; </span>
   <span class="font11">therapy </span>
   <span class="font11">{font-style </span>
   <span class="font11">{font-weight </span>
   <span class="font11">•No </span>
   <span class="font10">ACE </span>
   <span class="font10">Available </span>
   <span class="font10">Drug </span>
   <span class="font10">Engl </span>
   <span class="font10">Hepatol </span>
   <span class="font10">March </span>
   <span class="font10">Med[Epub </span>
   <span class="font10">Table </span>
   <span class="font10">[Accessed </span>
   <span class="font10">according </span>
   <span class="font10">acute-on-chronic </span>
   <span class="font10">additional </span>
   <span class="font10">admission </span>
   <span class="font10">admission. </span>
   <span class="font10">angiotensin-converting </span>
   <span class="font10">approved </span>
   <span class="font10">biopsy </span>
   <span class="font10">characteristics </span>
   <span class="font10">cirrhosis, </span>
   <span class="font10">countries </span>
   <span class="font10">courier; </span>
   <span class="font10">critically </span>
   <span class="font10">cytokine </span>
   <span class="font10">damage </span>
   <span class="font10">deferred </span>
   <span class="font10">diagnosis </span>
   <span class="font10">diagnostic </span>
   <span class="font10">dissemination </span>
   <span class="font10">elevated </span>
   <span class="font10">em; </span>
   <span class="font10">enzyme </span>
   <span class="font10">failure </span>
   <span class="font10">from: </span>
   <span class="font10">general </span>
   <span class="font10">guidelines </span>
   <span class="font10">hepatic </span>
   <span class="font10">hepatocellular </span>
   <span class="font10">infections </span>
   <span class="font10">information </span>
   <span class="font10">inhibitor </span>
   <span class="font10">injury </span>
   <span class="font10">laboratory </span>
   <span class="font10">levels </span>
   <span class="font10">limit </span>
   <span class="font10">model </span>
   <span class="font10">nosocomial </span>
   <span class="font10">observations </span>
   <span class="font10">patients, </span>
   <span class="font10">phone </span>
   <span class="font10">pneumonia </span>
   <span class="font10">possible </span>
   <span class="font10">presence </span>
   <span class="font10">protease </span>
   <span class="font10">pt;} </span>
   <span class="font10">recently </span>
   <span class="font10">reduced </span>
   <span class="font10">required </span>
   <span class="font10">therapeutic </span>
   <span class="font10">trials </span>
   <span class="font10">unknown </span>
   <span class="font10">used </span>
   <span class="font10">•Consider </span>
   <span class="font10">•Patients </span>
  </p>
 </body>
</html>
